← Open Payments lookup

EMILY DE ALBA: Open Payments

NPI 1639599574 · POPLAR BLUFF, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,627 in 82 payments from 11 companies in 2025. Trend: 2023 $851 · 2024 $1,054 · 2025 $1,627

Food & beverage: $1,619Education: $8
CompanyPaymentsAmount
Alkermes, Inc.21$440
Otsuka America Pharmaceutical, Inc.13$235
Teva Pharmaceuticals USA, Inc.10$188
Neurocrine BioSciences, Inc.11$187
Janssen Pharmaceuticals, Inc6$124
Vanda Pharmaceuticals Inc.4$101
E.R. Squibb & Sons, L.L.C.4$100
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$82
Axsome Therapeutics, Inc.4$78
Supernus Pharmaceuticals, Inc.2$47

Products named: ARISTADA, INGREZZA, UZEDY, ABILIFY MAINTENA, LYBALVI, REXULTI, FANAPT, COBENFY.

Industry payments across MO — which companies pay providers there.